DCM
DGX icon

Dean Capital Management’s Quest Diagnostics DGX Stock Holding History

Dean Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Hold
12,476
– – 0.96% 38
2026
Q1 		$2.45M Sell
12,476
-2
-0% -$389 1.01% 38
2025
Q4 		$2.17M Buy
12,478
+382
+3% +$69.6K 0.92% 38
2025
Q3 		$2.31M Hold
12,096
– – 0.9% 41
2025
Q2 		$2.17M Buy
12,096
+648
+6% +$113K 0.89% 39
2025
Q1 		$1.94M Buy
11,448
+217
+2% +$35.6K 0.84% 41
2024
Q4 		$1.69M Buy
11,231
+184
+2% +$28.6K 0.72% 69
2024
Q3 		$1.72M Buy
+11,047
New +$1.65M 0.73% 68
2024
Q2 		– Sell
-11,047
Closed -$1.47M – 100
2024
Q1 		$1.47M Hold
11,047
– – 0.86% 58
2023
Q4 		$1.52M Buy
11,047
+4,148
+60% +$545K 0.94% 41
2023
Q3 		$841K Buy
+6,899
New +$919K 0.63% 99
2021
Q1 		– Sell
-5,875
Closed -$700K – 91
2020
Q4 		$700K Sell
5,875
-364
-6% -$44.4K 0.42% 97
2020
Q3 		$714K Buy
6,239
+106
+2% +$12.5K 0.74% 56
2020
Q2 		$699K Buy
6,133
+664
+12% +$70.4K 0.82% 50
2020
Q1 		$439K Sell
5,469
-344
-6% -$35.6K 0.65% 88
2019
Q4 		$621K Buy
5,813
+75
+1% +$7.82K 0.59% 107
2019
Q3 		$614K Sell
5,738
-239
-4% -$24.5K 0.63% 78
2019
Q2 		$609K Buy
+5,977
New +$574K 0.63% 89

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Dean Capital Management's DGX Position: Q2 2026 in Review

Dean Capital Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 12,476 shares worth $2.64M. The position accounts for 0.96% of the portfolio, ranked #38.

Dean Capital Management first reported a position in DGX in Q2 2019 and has held it in 18 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Dean Capital Management held 12,476 shares of Quest Diagnostics worth $2.64M as of Q2 2026.
  • Dean Capital Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.96% of Dean Capital Management's portfolio in Q2 2026, its #38 holding.
  • Dean Capital Management first reported a position in Quest Diagnostics in Q2 2019 and has held it in 18 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Dean Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.